Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine for myocardial iron deposition in pediatric beta-thalassemia major
PACTR201902478249291Phase 2Completed
- Sponsor
- Beni-Suef University Hospital
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of amlodipine in beta thalassemia (2 arms), sponsored by Beni-Suef University Hospital. Primary endpoints: Change in myocardial iron concentration and Change in cardiac T2*. Started Oct 2017; status: completed.
02
Drugs
amlodipine
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on PACTR201902478249291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201902478249291.